Drinking more than one soft drink daily ? whether it?s regular or diet ? may be associated with an increase in the risk factors for heart disease, revealed by researchers.
According to a new study published online today in the Journal of the National Cancer Institute, prostate cancer patients treated by highly experienced surgeons are much more likely to be cancer-free five years after surgery than patients treated by surgeons with less experience.
Mammogram readings by both radiologists and nonphysician technologists improve breast cancer detection rates, according to a study in the July 24 Journal of the National Cancer Institute.
The medical community has been debating for many years whether, and to what extent, postmenopausal hormone therapy (HT) use is associated with a higher risk of breast cancer, says Professor Amos Pines, President of the International Menopause Society.
Students who break university rules on alcohol and drug use in residence halls are often sent to counseling or educational programs. Little is known about the long-term effectiveness of these interventions.
Heavy prenatal alcohol exposure does not always lead to fetal alcohol syndrome (FAS); sometimes it can lead to cognitive and behavioral deficits in the absence of craniofacial features needed to make an FAS diagnosis.
A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work.
Research on rats with crushed spinal cords, similar to human injury, reveals that treatment soon after injury combining radiation therapy to destroy harmful cells and microsurgery to drain excess fluids significantly increases the body?s ability to repair the injured cord leading to permanent recovery from injury, according to the study published in the July 18 peer-reviewed journal PLoS ONE.
Researchers at the Monell Chemical Senses Center have identified a genetically-transmitted metabolic defect that can lead to obesity in some individuals.
The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung.